Business | Schumpeter

The quest for a vaccine could restore faith in big pharma

The boffins of AstraZeneca are showing the way forward

UNPRECEDENTED IS AN overused word. But to find a parallel for the response of the pharmaceutical industry to the covid-19 pandemic, it is necessary to go back to the start of the second world war, another time when countries were desperate for miracle cures. Back then big pharmaceutical companies, especially in America, were as unproductive and unloved as they are today. People were appalled at the mis-selling of addictive narcotics, as they have been during the opioid crisis. And in pre-war Britain, scientists had discovered what they believed could be a wonder antibiotic—penicillin. Yet they could not find any firm, even in America, prepared to take the risk of producing it at scale.

This article appeared in the Business section of the print edition under the headline “Boffins v the bug”

The fire this time: Police violence, race and protest in America

From the June 6th 2020 edition

Discover stories from this section and more in the list of contents

Explore the edition

How Trump’s tariffs could crush American carmakers

They must hope the levies do not endure

A squirel in a suit sitting at a desk in front of a computer

The Economist’s office agony uncle is back

Another bulging postbag for Max Flannel


The illustration depicts a surreal figure with a head resembling the Belgian flag, balancing a cityscape on a tray in one hand and holding a car in the other. The figure's body is dressed like a performer, and two smoking exhaust pipes protrude from the ba

The smiling new face of German big business

From Allianz to Zalando, pedlars of services are outdoing industrial firms at home—and foreign rivals abroad


Airbus has not taken full advantage of Boeing’s weakness

That could leave a gap for other planemakers to fill

Zyn is giving investors a buzz—for now

Nicotine pouches are growing fast